AI assistant
Sending…
BioInvent International — Major Shareholding Notification 2011
Jul 15, 2011
3011_iss_2011-07-15_e5ec3e7f-c0dd-48fb-a56a-78b80a9309a8.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer BioInvent International Aktiebolag
Holder
DnB NOR Kapitalforvaltning AS
Instrument
| Instrument | Aktie SE0000789711 | |
|---|---|---|
| Before the transaction | ||
| Shares | 3,274,896 | |
| Voting rights | 3,274,896 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 14/07/2011 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 3,405,896 | |
| Directly held voting rights | 3,405,896 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 5.07 % | |
| Directly held voting rights | 5.07 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Notes (other relevant informations according to law) Ägandet består av innehav i värdepappersfonder förvaltade av DnB NOR Kapitalforvaltning AS.
Published
15/07/2011 10:15
Contact
Name Mikael Brovall Phone 08-473 44 04 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from BioInvent International
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
AGM Information
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 24
Interim / Quarterly Report
2026
Feb 26